Results 181 to 190 of about 30,237 (249)

The colistin resistance mcr-1 gene is going wild.

The Journal of antimicrobial chemotherapy, 2016
Liakopoulos, A., Mevius, D.J., Olsen, B., Bonnedahl, J.   +3 more
openaire   +4 more sources

Genomic characterization of plasmids of mcr-1-positive Escherichia coli isolated from cohabiting rats, dairy cattle and pigs. [PDF]

BMC Vet Res
Dominguez JE, Martino F, Lovera R, Casanova NA, Seah C, Cavia R, Corso A, Melano RG, Faccone D, Fernández Miyakawa ME.   +9 more
europepmc   +1 more source

Pathways Linking Socioeconomic Circumstances to Childhood Dental Caries: The Mediating Role of Parenting and Oral Health Behaviours Before and After Childsmile Implementation

Community Dentistry and Oral Epidemiology, EarlyView.
ABSTRACT Objectives To determine the extent that parenting styles and oral health behaviours mediate the relationship between socioeconomic circumstances (SEC) and childhood dental caries experience: pre−/post‐national roll‐out in 2011 of Childsmile, the child oral health improvement programme for Scotland.
Kyle Cousins, Mariél de Aquino Goulart, Paul Bradshaw, David I Conway, Andrea Sherriff   +4 more
wiley   +1 more source

First detection and genomic analysis of <i>mcr-1</i>-positive <i>Salmonella</i> Infantis isolated from a broiler production system in the United Arab Emirates. [PDF]

Front Vet Sci
Habib I, Mohamed MI, Lakshmi GB, Al Marzooqi HM, Afifi HS, Shehata MG, Elbediwi M.   +6 more
europepmc   +1 more source

Semaglutide Injection in Indian Patients With Type 2 Diabetes Mellitus: A Randomised, Phase III, Active‐Controlled Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim To evaluate the efficacy, safety and immunogenicity of semaglutide injection (synthetic) (Test group) compared with the Reference semaglutide injection [Ozempic, (Reference group)] in Indian patients with Type 2 diabetes mellitus (T2DM).
Unnikrishnan Ambika Gopalakrishnan, Ameya Sudhakar Joshi, Richa Giri, Shalin Jagdeep Shah, Jitendra Shukla, Sanjiv Maheshwari, Rekha M. Chowdaiah, Manish Kumar Singh, Aditya Srirang Bari, Niranjan Pandurang Pathak, Akash Nitinbhai Shah, Shweta Bhandari, Ambanna Gowda, Ambrish Chandrappa, Pravin Dinkar Supe, Bharat Das, Prabhat Kumar Sharma, Mehul Kalubhai Virani, Prakash Harishchandra Kurmi, Gayatri Amit Ghanekar, Mani Deepathi Dasari, Banshidhar Sahoo, Sanjay Kumar Jangid, Prakash Sadashiv Shende, Sandesh Sahebarao Patil, Avinash Narayan Kumbhar, Shrikant Vishnu Deshpande, Madhusudhan Chennappa, Nitesh Chandubhai Patel, Dipesh Sonawane, Dipak Patil, Sucheta Pandit, Pravin Ghadge, Suyog Mehta   +33 more
wiley   +1 more source

Escherichia coli ST542 Co-Harbouring bla _NDM-1 and mcr-1 in a Pig Farm, China. [PDF]

Infect Drug Resist
Shao PY, Jiang Y, Mei CY, Li W, Wang ZY, Jiao X, Wang J, Sun L.   +7 more
europepmc   +1 more source

Multi‐Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Empagliflozin is renoprotective in Type 2 diabetes mellitus (T2DM). Our primary aim was to assess empagliflozin's effect on glomerular filtration rate and renal vascular resistance using multiparametric MRI (MpMRI). Our secondary aim was to assess the impact of empagliflozin on additional MpMRI‐derived metrics including markers of tissue ...
Ruth P. Lim, Salma Qassin, Lucy McKenna, Emma Hornsey, Dominic Italiano, Leonid Churilov, Richard J. MacIsaac, Jas‐mine Seah, Elif I. Ekinci, The Austin EMPA‐MRI Study Group   +9 more
wiley   +1 more source

Intestinal flora metabolites indole-3-butyric acid and disodium succinate promote IncI2 <i>mcr-1-</i>carrying plasmid transfer. [PDF]

Front Cell Infect Microbiol
Xu J, Zhang M, Yan Y, Li Z, Lu X.
europepmc   +1 more source

One Week Exposure to a Somatostatin Receptor 2 Antagonist (SSTR2a) Enhances Glucagon Counterregulation to Insulin‐Induced Hypoglycaemia and Does Not Worsen Glycemia in a Male Rat Model of Insulin‐Requiring Type 2 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Introduction Administration of a somatostatin receptor 2 antagonist (SSTR2a) increases glucagon responsiveness to hypoglycaemia in insulin‐treated type 2 diabetes (T2D), but the durability of this effect and the impact of repeated SSTR2a dosing on overall glycaemia in T2D are unclear.
Ninoschka C. D'Souza, Emily G. Hoffman, Sara C. Atherley, Sabrina Champsi, Nadia Aleali, Richard T. Liggins, Owen Chan, Michael C. Riddell   +7 more
wiley   +1 more source